References
1 Profeta G, Micangeli G, Tarani F, et al. Sexual developmental disorders in pediatrics[J]. Clin Ter, 2022, 173(5): 475-488. PMID: 36155734. DOI: 10.7417/CT.2022.2466.
2 Alimussina M, Diver LA, McGowan R, et al. Genetic testing of XY newborns with a suspected disorder of sex development[J]. Curr Opin Pediatr, 2018, 30(4): 548-557. PMID: 29782383. DOI: 10.1097/MOP.0000000000000644.
3 Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders[J]. J Pediatr Urol, 2006, 2(3): 148-162. PMID: 18947601. DOI: 10.1016/j.jpurol.2006.03.004.
4 Ahmad A, Ayub F, Saleem I, et al. Initial assessment of a child with suspected disorder of sex development[J]. J Pak Med Assoc, 2019, 69(5): 711-717. PMID: 31105293.
5 Liu Q, Yin X, Li P. Clinical characteristics, AR gene variants, and functional domains in 64 patients with androgen insensitivity syndrome[J]. J Endocrinol Invest, 2023, 46(1): 151-158. PMID: 35974208. PMCID: PMC9829593. DOI: 10.1007/s40618-022-01894-4.
6 中华医学会小儿外科学分会泌尿外科学组. 性别发育异常中国专家诊疗共识[J]. 中华小儿外科杂志, 2019, 40(4): 289-297. DOI: 10.3760/cma.j.issn.0253-3006.2019.04.001.
7 中华医学会儿科学分会. 儿科内分泌与代谢性疾病诊疗规范[M]. 北京: 人民卫生出版社, 2016: 97-100.
8 Ishii T, Matsuo N, Sato S, et al. Human chorionic gonadotropin stimulation test in prepubertal children with micropenis can accurately predict leydig cell function in pubertal or postpubertal adolescents[J]. Horm Res Paediatr, 2015, 84(5): 305-310. PMID: 26352728. DOI: 10.1159/000439234.
9 中华医学会儿科学分会内分泌遗传代谢学组. 性发育异常的儿科内分泌诊断与治疗共识[J]. 中华儿科杂志, 2019, 57(6): 410-418. PMID: 31216796. DOI: 10.3760/cma.j.issn.0578-1310.2019.06.003.
10 Bertelloni S, Russo G, Baroncelli GI. Human chorionic gonadotropin test: old uncertainties, new perspectives, and value in 46,XY disorders of sex development[J]. Sex Dev, 2018, 12(1-3): 41-49. PMID: 29131089. DOI: 10.1159/000481552.
11 Oliveira LR, Homma TK, Woloszynek RR, et al. Gonadal response after a single-dose stimulation test with recombinant human chorionic gonadotropin (rhCG) in patients with isolated prepubertal cryptorchidism[J]. Basic Clin Androl, 2016, 26: 13. PMID: 27800162. PMCID: PMC5084384. DOI: 10.1186/s12610-016-0039-2.
12 Grinspon RP, Castro S, Rey RA. Up-to-date clinical and biochemical workup of the child and the adolescent with a suspected disorder of sex development[J]. Horm Res Paediatr, 2023, 96(2): 116-127. PMID: 34781296. DOI: 10.1159/000519895.
13 Fendereski K, Carey J, Timme K, et al. 46 XY undervirulized male DSD: reporting a patient with prenatally diagnosed disorder/difference of sex development (DSD) with heterozygous LHCGR mutations[J]. Urol Case Rep, 2021, 41: 101971. PMID: 34950567. PMCID: PMC8671494. DOI: 10.1016/j.eucr.2021.101971.
14 Das S, Saikia UK, Saikia KK, et al. "Spectrum of 46 XY disorders of sex development": a hospital-based cross-sectional study[J]. Indian J Endocrinol Metab, 2020, 24(4): 360-365. PMID: 33088761. PMCID: PMC7540835. DOI: 10.4103/ijem.IJEM_98_20.
15 Jaruratanasirikul S, Engchaun V. Management of children with disorders of sex development: 20-year experience in southern Thailand[J]. World J Pediatr, 2014, 10(2): 168-174. PMID: 23775676. DOI: 10.1007/s12519-013-0418-0.
16 Zhuang J, Chen C, Li J, et al. The 46, XX ovotesticular disorder of sex development with Xq27.1q27.2 duplication involving the SOX3 gene: a rare case report and literature review[J]. Front Pediatr, 2021, 9: 682846. PMID: 34178900. PMCID: PMC8225946. DOI: 10.3389/fped.2021.682846.
17 王斯嘉, 方兰兰, 于医萍, 等. 核磁共振联合超声成像在性发育异常诊断中的应用研究[J]. 中华生殖与避孕杂志, 2019, 39(9): 756-762. DOI: 10.3760/cma.j.issn.2096-2916.2019.09.012.
18 Spoor JA, Oosterhuis JW, Hersmus R, et al. Histological assessment of gonads in DSD: relevance for clinical management[J]. Sex Dev, 2018, 12(1-3): 106-122. PMID: 29131109. DOI: 10.1159/000481757.
19 Kim HI, Lee I, Kim SH, et al. Ovotesticular disorder of sex development in Korean children: a single-center analysis over a 30-year period[J]. J Pediatr Adolesc Gynecol, 2021, 34(5): 626-630. PMID: 33667640. DOI: 10.1016/j.jpag.2021.02.105.
20 伊鹏, 牛会林, 高秋, 等. 儿童性发育异常性腺病理学观察[J]. 中华病理学杂志, 2018, 47(7): 531-535. PMID: 29996319. DOI: 10.3760/cma.j.issn.0529-5807.2018.07.010.
21 Han B, Zhu H, Yao H, et al. Differences of adrenal-derived androgens in 5α-reductase deficiency versus androgen insensitivity syndrome[J]. Clin Transl Sci, 2022, 15(3): 658-666. PMID: 34755921. PMCID: PMC8932821. DOI: 10.1111/cts.13184.
22 de Oliveira LR, Longui CA, Guaragna-Filho G, et al. Suggested cutoff point for testosterone by liquid chromatography with tandem mass spectrometry (LC-MS/MS) after stimulation with recombinant human chorionic gonadotropin[J]. Sex Dev, 2022, 16(4): 266-269. PMID: 34903701. DOI: 10.1159/000519422.
23 Maimoun L, Philibert P, Cammas B, et al. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients[J]. J Clin Endocrinol Metab, 2011, 96(2): 296-307. PMID: 21147889. DOI: 10.1210/jc.2010-1024.
24 Bertelloni S, Baldinotti F, Russo G, et al. 5α-Reductase-2 deficiency: clinical findings, endocrine pitfalls, and genetic features in a large Italian cohort[J]. Sex Dev, 2016, 10(1): 28-36. PMID: 27070133. DOI: 10.1159/000445090.
25 Li L, Zhang J, Li Q, et al. Mutational analysis of compound heterozygous mutation p.Q6X/p.H232R in SRD5A2 causing 46, XY disorder of sex development[J]. Ital J Pediatr, 2022, 48(1): 47. PMID: 35331321. PMCID: PMC8944008. DOI: 10.1186/s13052-022-01243-4.